Autoimmune blistering diseases in children: Signposts in the process of evaluation

Clinics in Dermatology

Volumn 18, Issue 6, 2000, Pages 711-724

  Brenner, Sarah ^a,b   Mashiah, Jacob ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; BLISTER; BULLOUS DERMATITIS; CHILD; DERMATITIS HERPETIFORMIS; HUMAN; MUCOUS MEMBRANE PEMPHIGOID; PEMPHIGOID; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; SKIN DISEASES, VESICULOBULLOUS;

EID: 0034496453     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(00)00154-1     Document Type: Review

References (183)

1. Pemphigus vulgaris in a 13-year-old girl
2. Childhood, neonatal, and stillborn pemphigus Vulgaris
3. Childhood pemphigus vulgaris
4. Pemphigus vulgaris in childhood; Clinical features, treatment and prognosis
5. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion
6. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris; A model for autoimmunity
7. Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris
8. Distribution of HLA class II alleles among Spanish patients with pemphigus vulgaris
9. PCR determination of an association between class II HLA and pemphigus vulgaris
10. The chronic acquired bullous diseases of childhood. Review article
11. Pemphigus vegetans in a child
12. Pemphigus vegetans in a 4-year-old boy
13. Childhood pemphigus
14. Epidermal antigen and complement-binding anti-intercellular antibodies in pemphigus vegetans, Hallopeau type
15. Pemphigus foliaceus or erythema multiforme
16. Immunofluorescent studies of pemphigus foliaceus in a child
17. True childhood pemphigus. Pemphigus foliaceus in an 18-month-old child; Immunofluorescence as a diagnostic aid
18. Pemphigus foliaceus in a child. A two-year follow-up under steroid. An immunosuppression therapy
19. Childhood pemphigus foliaceus. Report of a case
20. Pemphigus foliaceus in a haemophilic child; Cytomegalovirus induction?
21. Coexisting childhood pemphigus foliaceus and Graves' disease
22. Childhood pemphigus foliaceus; Case report and review of the literature
23. Pemphigus foliaceus in an 8-year-old girl
24. Childhood pemphigus foliaceus
25. Neonatal pemphigus foliaceus
26. Pemphigus foliaceus in a child
27. Further experience with pemphigus in children
28. Superficial pemphigus in children. Induction role of amoxicillin?
29. Superficial pemphigus in children. Induction by amoxicillin?
30. Juvenile pemphigus foliaceus
31. Juvenile pemphigus foliaceus; Response to dapsone
32. Juvenile pemphigus foliaceus treated with sublesional corticosteroids
33. Exfoliative type juvenile pemphigus foliaceus; A case report
34. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus
35. Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein
36. Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients
37. Brazilian pemphigus foliaceus, endemic pemphigus foliaceus, or fogo selvagem (wild fire)
38. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem)
39. Affinity immunoblotting studies on the restriction of autoantibodies from endemic pemphigus foliaceus
40. Endemic pemphigus foliaceus (fogo selvagem); II. Current and historic epidemiologic studies
41. Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). The Cooperative Group on Fogo Selvagem Research
42. Diet and pemphigus. In pursuit of exogenous factors in pemphigus and fogo selvagem
43. Pemphigus and diet. Have we solved the mystery of fogo selvagem?
44. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations
45. The prevalence of antibodies against desmoglein I in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research
46. Pemphigus erythematosus in a five-year-old child
47. Pemphigus erythematosus; Detection of anti-desmoglein-1 antibodies by ELISA
48. A congenital acantholytic bullous eruption in the newborn infant of a pephigus mother
49. Neonatal pemphigus vulgaris
50. Neonatal pemphigus foliaceus
51. In vivo bound pemphigus antibodies in a stillborn infant; Passive intrauterine transfer of pemphigus vulgaris?
52. Maternal pemphigus vulgaris with in vivo bound antibodies in the stillborn fetus
53. Transplacental transmission of pemphigus
54. Pemphigus in pregnancy; A reevaluation of fetal risk
55. Neonatal pemphigus vulgaris; Role of passively transferred pemphigus antibodies
56. Neonatal pemphigus vulgaris; Transplacental transmission of antibodies
57. Neonatal pemphigus vulgaris
58. Neonatal pemphigus
59. Pemphigus neonatorum
60. Pemphigus vulgaris and pregnancy
61. Neonatal pemphigus vulgaris in a child born to a woman in remission
62. Neonatal pemphigus vulgaris associated with mild oral pemphigus vulgaris in the mother during pregnancy
63. Protection against pemphigus foliaceus by desmoglein III in neonates
64. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia
65. Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma
66. Childhood paraneoplastic pemphigus associated with Castelman's tumour
67. Bullous skin diseases
68. Subcorneal pustular dermatosis and monoclonal IgA
69. Pemphigus-like IgA deposits and vesiculo-pustular eruption in a 10-year-old girl
70. IgA pemphigus in a child
71. Intercellular IgA dermatosis of childhood
72. Pustulose intraepidermique a IgA chez un enfant. Mise en evidence d'un antigene cible identique a celui du pemphigus superficial
73. A novel childhood pemphigus vegetans variant of intraepidermal neutrophilic IgA dermatosis
74. Bullous pemphigoid in an 11-year-old boy
75. Childhood bullous pemphigoid
76. Bullous pemphigoid in children. Report of three cases with special emphasis on therapy
77. Childhood localized vulvar pemphigoid is a true variant of bullous pemphigoid
78. Bullous pemphigoid in infancy-a case report including new immunoblotting observations
79. Annular bullous pemphigoid in a child
80. Childhood bullous pemphigoid; Immunohistochemical, immunoelectron microscopic, and Western blot analysis
81. Bullous pemphigoid in a 4-month-old boy
82. Bullous pemphigoid in an infant
83. Childhood bullous pemphigoid-report of a case with dermal fluorescence on salt-split skin
84. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant
85. Bullous pemphigoid in an infant; A case report and literature review
86. Vesicobullous lesions in a child. Bullous pemphigoid (BP)
87. Bullous pemphigoid in infancy; Case report and literature review
88. Childhood bullous pemphigoid associated with chronic renal allograft rejection
89. Bullous pemphigoid in a 2-month-old infant
90. Childhood bullous pemphigoid; Report of a case with characterization of the targeted antigens
91. Childhood bullous pemphigoid associated with IgA antibodies against BP180 or BP230 antigens
92. Bullous pemphigoid of childhood; Autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood
93. Subclass characterization of IgG autoantibodies in bullous pemphigoid and pemphigus
94. Polymorphism of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid
95. The association of HLA-DQ7 with bullous pemphigoid is restricted to men
96. HLA in bullous pemphigoid. The probable role of HLA-B7 as a marker for poor responders to immunosuppressive therapy
97. Probable association between HLA-DR5 and bullous pemphigoid
98. Erythromycin therapy in bullous pemphigoid; Possible anti-inflammatory effects
99. Cicatricial pemphigoid in a young girl; Report of a case
100. Cicatricial pemphigoid in a 6-year-old child; Report of a case and review of the literature
101. Cicatricial pemphigoid in a 4-year-old child
102. Desquamative gingivitis in a 13-year-old male
103. Gingival manifestation of childhood cicatricial pemphigoid
104. Childhood cicatricial pemphigoid with linear IgA deposits; A case report
105. Cicatricial pemphigoid; A case of onset at age 5
106. Acquired bullous diseases of childhood; Reevaluation by direct immunofluorescence examination on 1 M NaCl split skin and immunobloting
107. Chronic bullous disease of childhood, childhood cicatricial pemphigoid and linear IgA disease of adults
108. The localization of the binding site of circulating IgA antibodies in linear IgA of adults, chronic bullous disease of childhood, and cicatricial pemphigoid
109. Disseminated cicatricial pemphigoid in a child and in an adult. Ultrastructural diagnostic criteria and differential diagnosis with special reference to acquired epidermolysis bullosa
110. Ocular cicatricial pemphigoid. A case report of monozygotic twins discordant for the disease
111. The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita
112. HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians
113. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid
114. Herpes gestationis. A new assessment of incidence, diagnosis, and fetal prognosis
115. Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women
116. Fetal risks in herpes gestationis
117. Herpes gestationis; Clinical and histologic features of twenty-eight cases
118. Herpes gestationis in mother and erythemato-pustulous rash in the newborn with positive direct immunofluorescence. A transfer of the disease?
119. Herpes gestationis with transient bullous lesions in the newborn
120. IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis
121. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen
122. Herpes gestationis
123. Class II MHC typing in pemphigoid gestationis
124. Childhood vulval pemphigoid; A clinical and immunopathological study of five patients
125. Localized vulval pemphigoid in a child
126. Localized childhood vulval pemphigoid
127. Bullous pemphigoid in children. Report of three cases with special emphasis on therapy
128. Localized vulval pemphigoid in a child misdiagnosed as sexual abuse
129. Childhood localized vulval pemphigoid is a true varient of bullous pemphigoid
130. A child with localized vulval pemphigoid and IgG autoantibodies targeting the C-terminus of collagen XVII/BP180
131. Epidermolysis bullosa acquisita
132. Epidermolysis bullosa acquisita; Ultrastructural and immunological studies
133. Epidermolysis bullosa acquisita in childhood
134. Epidermolysis bullosa acquisita in childhood
135. Epidermolysis bullosa acquisita in childhood-a case mimicking chronic bullous dermatosis of childhood
136. Epidermolysis bullosa acquisita in a 6-year-old Japanese boy
137. Epidermolysis bullosa acquisita in a 4-year-old boy
138. Epidermolysis bullosa acquisita in two children
139. IgA-epidermolysis bullosa acquisita in a child resulting in blindness
140. Childhood bullous dermatitis herpetiformis-negative immunofluorescent tests
141. Chronic bullous dermatitis of childhood-clinical and immunological features seen in African patients
142. Chronic bullous disease of childhood
143. Case reports of linear IgA bullous dermatosis of childhood
144. Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases
145. Immunoelectronmicroscopic differentiation of linear IgA bullous dermatosis of adults with coexistence of IgA and IgG deposition from bullous pemphigoid
146. Use of 1 M NaCl split skin in the indirect immunoflourescence of the linear IgA bullous dermatoses
147. The localization of target antigens and autoantibodies in linear IgA disease is variable; Correlation of immunogold electron microscopy and immunoblotting
148. IgA antibodies in chronic bullous disease of childhood react with a 97-kDa basement membrane zone protein
149. Drug-induced linear IgA disease; Target antigens are heterogeneous
150. Adult linear IgA disease and chronic bullous disease of childhood; The association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression
151. Distribution of the antigen in adult linear IgA disease and chronic bullous dermatosis of childhood suggests that it is a single and unique antigen
152. Linear IgA bullous dermatosis of adults and children; An immunoelectron microscopic study
153. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency
154. Drug-induced linear IgA bullous dermatosis probably induced by furosemide
155. Dermatitis herpetiformis
156. Dermatitis herpetiformis; Jejunal findings and skin response to gluten-free diet
157. The incidence and prevalence of dermatitis herpetiformis in Utah
158. Clinical features of dermatitis herpetiformis
159. Dermatitis herpetiformis in two American blacks; HLA type and clinical characteristics
160. The small intestine in dermatitis herpetiformis
161. Gluten-free diet in dermatitis herpetiformis. II. Morphological and immunological findings in the skin and small intestine of 12 patients and matched controls
162. Clearence of skin lesions in dermatitis herpetiformis after gluten withdrawel
163. Gluten challenge in dermatitis herpetiformis
164. Antireticulin antibody; Incidence and diagnostic significance
165. Antireticulin antibody in dermatitis herpetiformis and adult coeliac disease. Their relationship to a gluten-free diet and jejunal histology
166. Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid
167. Immunofluorescent studies in the diagnosis of dermatitis herpetiformis and its differentiation from bullous pemphigoid
168. Immunofluorescent localization of basement membrane in lesions of dermatitis herpetiformis
169. Cutaneus IgA subclasses in dermatitis herpetiformis and linear IgA disease
170. HLA in juvenile dermatitis herpetiformis; Clinical heterogeneity correlated with DNA and serological polymorphism
171. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988
172. Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone
173. Treatment of dermatitis herpetiformis with colchicine
174. Bullous dermatosis and systemic lupus erythematosus in a 15-year-old boy
175. Systemic lupus erythematosus presenting as a bullous eruption in a child
176. Localized linear bullous eruption of systemic lupus erythematosus in a child
177. Bullous systemic lupus erythematosus; Detection of antibodies against noncollagenous domain of type VII collagen
178. Bullous eruption of systemic lupus erythematosis. Dramatic response to dapsone therapy
179. Bullous systemic lupus erythematosus
180. Bullous SLE; A phenotypically distinctive but immunologically heterogeneous bullous disorder
181. Systemic lupus erythematosus with vesiculobullous lesions. Immunoelectron microscopic studies
182. Evidence suporting a role for second hypervariable region of the DR beta-1 gene in susceptibility to type VII collagen autoimmunity